BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15735717)

  • 1. Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy.
    Romero-Gallo J; Sozmen EG; Chytil A; Russell WE; Whitehead R; Parks WT; Holdren MS; Her MF; Gautam S; Magnuson M; Moses HL; Grady WM
    Oncogene; 2005 Apr; 24(18):3028-41. PubMed ID: 15735717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice.
    Oe S; Lemmer ER; Conner EA; Factor VM; Levéen P; Larsson J; Karlsson S; Thorgeirsson SS
    Hepatology; 2004 Nov; 40(5):1098-105. PubMed ID: 15389868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer.
    Biswas S; Chytil A; Washington K; Romero-Gallo J; Gorska AE; Wirth PS; Gautam S; Moses HL; Grady WM
    Cancer Res; 2004 Jul; 64(14):4687-92. PubMed ID: 15256431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of transforming growth factor beta signaling in caveolin-1-deficient hepatocytes: role in liver regeneration.
    Mayoral R; Valverde ÁM; Llorente Izquierdo C; González-Rodríguez Á; Boscá L; Martín-Sanz P
    J Biol Chem; 2010 Feb; 285(6):3633-3642. PubMed ID: 19966340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta inactivation and TGF-alpha overexpression cooperate in an in vivo mouse model to induce hepatocellular carcinoma that recapitulates molecular features of human liver cancer.
    Baek JY; Morris SM; Campbell J; Fausto N; Yeh MM; Grady WM
    Int J Cancer; 2010 Sep; 127(5):1060-71. PubMed ID: 20020490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
    Morris SM; Baek JY; Koszarek A; Kanngurn S; Knoblaugh SE; Grady WM
    Hepatology; 2012 Jan; 55(1):121-31. PubMed ID: 21898503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration.
    Macias-Silva M; Li W; Leu JI; Crissey MA; Taub R
    J Biol Chem; 2002 Aug; 277(32):28483-90. PubMed ID: 12023281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenchymal transforming growth factor beta-1: its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology.
    Calabrese F; Valente M; Giacometti C; Pettenazzo E; Benvegnu L; Alberti A; Gatta A; Pontisso P
    J Gastroenterol Hepatol; 2003 Nov; 18(11):1302-8. PubMed ID: 14535988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta1 released from the spleen exerts a growth inhibitory effect on liver regeneration in rats.
    Ueda S; Yamanoi A; Hishikawa Y; Dhar DK; Tachibana M; Nagasue N
    Lab Invest; 2003 Nov; 83(11):1595-603. PubMed ID: 14615413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice.
    Yang L; Roh YS; Song J; Zhang B; Liu C; Loomba R; Seki E
    Hepatology; 2014 Feb; 59(2):483-95. PubMed ID: 23996730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
    Busch S; Acar A; Magnusson Y; Gregersson P; Rydén L; Landberg G
    Oncogene; 2015 Jan; 34(1):27-38. PubMed ID: 24336330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β signaling alters the pattern of liver tumorigenesis induced by Pten inactivation.
    Morris SM; Carter KT; Baek JY; Koszarek A; Yeh MM; Knoblaugh SE; Grady WM
    Oncogene; 2015 Jun; 34(25):3273-82. PubMed ID: 25132272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Transforming Growth Factor-β and H19 Signaling Axis in Tumor-Initiating Hepatocytes That Regulates Hepatic Carcinogenesis.
    Zhang J; Han C; Ungerleider N; Chen W; Song K; Wang Y; Kwon H; Ma W; Wu T
    Hepatology; 2019 Apr; 69(4):1549-1563. PubMed ID: 30014520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of Tgfbr2 in hepatocytes alleviates liver fibrosis and restores hepatic function in fibrotic mice.
    Liu SQ; Deng X; Zhu CP; Cui YL; Xie WF; Zhang X
    J Dig Dis; 2023 Jan; 24(1):39-50. PubMed ID: 36967587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo.
    Yu M; Trobridge P; Wang Y; Kanngurn S; Morris SM; Knoblaugh S; Grady WM
    Oncogene; 2014 Mar; 33(12):1538-47. PubMed ID: 23604118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
    Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
    Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
    Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
    Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reticulon 4B (Nogo-B) facilitates hepatocyte proliferation and liver regeneration in mice.
    Gao L; Utsumi T; Tashiro K; Liu B; Zhang D; Swenson ES; Iwakiri Y
    Hepatology; 2013 May; 57(5):1992-2003. PubMed ID: 23299899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway.
    Trobridge P; Knoblaugh S; Washington MK; Munoz NM; Tsuchiya KD; Rojas A; Song X; Ulrich CM; Sasazuki T; Shirasawa S; Grady WM
    Gastroenterology; 2009 May; 136(5):1680-8.e7. PubMed ID: 19208363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.